ACS Applied Bio Materials · 2024 · 15 citations · 103 references
PharmacyPharmacologyPharmacotherapyDrug DeliveryNanoparticle Drug DeliveryStimuli-responsive Drug DeliveryLipid-based NanoparticlesNanocarriers For TherapeuticsNanomaterials For Drug DeliveryNanomedicineNanoparticle DesignRetinal PharmacotherapyDrug Delivery NanocarriersDrug Delivery To The RetinaLipid NanoparticlesNanocarriersResponsive NanocarriersSmart Drug Delivery SystemsTargeted Delivery To The RetinaTransport Across Ocular Barriers
Retinal diseases, such as age-related macular degeneration, diabetic retinopathy, and retinoblastoma, stand as the leading causes of irreversible vision impairment and blindness worldwide. Effectively administering drugs for retinal diseases poses a formidable challenge due to the presence of complex ocular barriers and elimination mechanisms. Over time, various approaches have been developed to fabricate drug delivery systems for improving retinal therapy including virus vectors, lipid nanoparticles, and polymers. However, conventional nanocarriers encounter issues related to the controllability, efficiency, and safety in the retina. Therefore, the development of smart nanocarriers for effective or more invasive long-term treatment remains a desirable goal. Recently, approaches have surfaced for the intelligent design of nanocarriers, leveraging specific responses to external or internal triggers and enabling multiple functions for retinal therapy such as topical administration, prolonged drug release, and site-specific drug delivery. This Review provides an overview of prevalent retinal pathologies and related pharmacotherapies to enhance the understanding of retinal diseases. It also surveys recent developments and strategies employed in the intelligent design of nanocarriers for retinal disease. Finally, the challenges of smart nanocarriers in potential clinical retinal therapeutic applications are discussed to inspire the next generation of smart nanocarriers.
103
Global Prevalence of Diabetic Retinopathy and Projection of Burden through 2045
Zhen Ling Teo, Yih Chung Tham, Marco Yu et al. · Ophthalmology · 2021 · 2.2K citations
Stephen R. Russell, Jean Bennett, Jennifer Wellman et al. · The Lancet · 2017 · 1.9K citations
Clinical Classification of Age-related Macular Degeneration
Frederick L. Ferris, Charles P. Wilkinson, Alan C. Bird et al. · Ophthalmology · 2013 · 1.8K citations · Full text
Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration
Daniel Martín, Maureen G. Maguire, Stuart L. Fine et al. · Ophthalmology · 2012 · 1.7K citations · Full text
American Journal of Ophthalmology · 2001 · 818 citations